Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

DTC Ad Final Rule Means Reliance On PhRMA Program Risks Enforcement Action – Azar

May 08 2019

• By Cathy Kelly

Compliance

Related Content

DTC Ad Proposal: Biopharma, Advertisers Marshall Legal Arguments In Opposition

Dec 19 2018

PhRMA’s Defensive Move On DTC Ads: Putting Drug List Prices ‘In Context’

Oct 16 2018

Trump Administration's Rx-Price-Disclosure Reg Sets Up Legal Fight With PhRMA

Oct 16 2018

Trump Administration's Rx Drug Price Disclosure Reg Seen As Unworkable

Oct 21 2018

Related Companies

Pfizer Inc.

Additional Topics

United States Ad Campaigns Pricing Debate Pricing Strategies Regulation Advertising, Marketing & Sales BioPharmaceutical

More from Marketing & Advertising

More from Compliance

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window